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Abstract 
Current strategies for bone repair have accepted limitations and the search for synthetic graft 
materials or for scaffolds that will support ex vivo bone tissue engineering continues. Biomimetic 
strategies have led to the investigation of naturally occurring porous structures as templates for bone 
growth. The marine environment is rich in mineralizing organisms with porous structures, some of 
which are currently being used as bone graft materials and others that are in early stages of 
development. This review describes the current evidence available for these organisms, considers the 
relative promise of each and suggests potential future directions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Bone grafting is used routinely in orthopaedic and dental surgery for procedures such as spinal fusion, 
foot and ankle arthrodesis, impaction grafting during revision surgery, stimulation of healing in 
fracture non-unions and void filling following tumour resection. In the reconstruction of bony deficits, 
autologous or allogenic bone has proven most effective, however, their use is not without problems. 
Autograft harvest has associated significant donor site morbidity and restrictions on the amount of 
graft material available, particularly if the patient is elderly and bone stock is deteriorating. Allograft 
also has limited stocks(Galea et al., 1998), a clinical failure rate of 20-30% and concerns about 
immunogenicity (Louisia et al., 1999; Summers and Eisenstein, 1989; Wooley et al., 1996). 
Furthermore, it is likely that with increasing concerns over transmissible spongiform 
encephalopathies the use of allograft material will be more tightly regulated and restricted in the near 
future.  
 
Currently, the majority of clinically available and experimental synthetic bone graft materials are 
calcium phosphate (CaP) ceramics. Approximately 60% of bone consists of the mineral phase 
hydroxyapatite (HA), therefore structures containing HA or related CaPs, (e.g. beta-tricalcium 
phosphate) are natural choices as bone substitutes and scaffolds for bone tissue engineering (Rezwan 
et al., 2006). Although the biological performance of CaPs is well proven and they possess excellent 
biocompatibility and osteoconductive properties, clinical results continue to be inferior to those seen 
with autograft or allograft. Therefore, development of new or modified synthetic bone substitutes 
continues apace (Bohner et al., 2005).  
 
It is the general consensus among the scientific and orthopaedic communities that the ideal material 
for bone tissue engineering should provide initial mechanical strength and support, with gradual 
resorption and replacement by newly synthesized host tissue. When calcium phosphates were first 
investigated as bone graft substitutes, dense material in granule or particulate form was often 
implanted but as these ceramics are only partially resorbable, replacement by new bone is incomplete 
and the biomaterial remains in situ for many years.  Development of advanced production methods 
and a desire to mimic more closely the natural structure of bone led to the production of porous 
materials that are more easily infiltrated by host tissue (Shors, 1999). Porous materials allow 
improved interdigitation with host bone, improved vascularization and fluid exchange. Several studies 
have suggested that the optimum pore size for neovascularization and bone ingrowth is between 200 
m and 500 m (Green et al., 2002; Wiesmann et al., 2004) and that good connectivity of the pores 
throughout the scaffold is essential (Shors, 1999). This advancement in design, coupled with the 
principles of biomimetics and an interest in ex vivo tissue engineering of bone has led to a search for 
naturally occurring scaffolds that could be used for the purpose of bone regeneration.   
 
The marine environment is a rich source of organisms with unique bone-like structures. Coral has 
been the most widely used – in the early 1970s, White (White, 1997) suggested that a variety of corals 
and echinoids with unique 3-D structures, described by Weber in the 1960s, may have a potential 
application for orthopaedics – but in the last five years, calcified materials from a diverse range of 
marine invertebrates have been investigated for use in bone tissue engineering. This review will 
compare the published results for each of these sources and will consider the relative promise of each 
organism, taking into consideration concerns of sustainability and conservation.  
 
Coral 
Corals belong to the phylum Cnidaria, and most belong to class Anthozoa (Castro and Huber, 2008). 
Many soft corals have an internal structure that features calcium carbonate spicules but it is the hard, 
or stony, corals which are used for bone tissue engineering (Shors, 1999). Stony corals secrete an 
external calcium carbonate skeleton, mainly in the form of aragonite with some calcite (Abramovitch-
Gottlib et al., 2006; Allemand et al., 1998). This skeleton, combined with an open, highly 
interconnected porous structure, make them of interest as scaffolds for bone tissue engineering. Most 
of the corals that have been investigated thus far for use as scaffolds for bone growth have pore sizes 
between 100 m and 50 0m diameter with a high degree of connectivity (Abramovitch-Gottlib et al., 
2006; Geiger et al., 2007; Green et al., 2002; Mygind et al., 2007; Shors, 1999; Wiesmann et al., 2004).  
 
Clinically, coral scaffolds or coral-derivatives have been used for spinal fusion (Coughlin et al., 2006; 
Griesshaber et al., 2007; Im et al., 2005), in maxillofacial surgery (Chen et al., 2008b; Green et al., 
2003; Laza et al., 2007; Oliveira et al., 2007), dental surgery (Lahaye and Robic, 2007; Martina et al., 
2005) and for other orthopaedic applications (Bachle et al., 2006; Coughlin et al., 2006; Hou et al., 
2007; Kujala et al., 2002), either alone (Chen et al., 2008b; Coughlin et al., 2006; Green et al., 2003; 
Hou et al., 2007; Im et al., 2005; Lahaye and Robic, 2007; Laza et al., 2007; Oliveira et al., 2007), or as 
part of a composite material (Bachle et al., 2006; Coughlin et al., 2006; Griesshaber et al., 2007; 
Martina et al., 2005) with reported success and low complication rates, an exception being a clinical 
study of scaphoid non-unions in which autograft was supplemented with coral/BMP implants and 
poor results were blamed on poor vascularity (Kujala et al., 2002). 
 
Experimentally, in vitro testing of corals directly as scaffolds to support osteogenic cell attachment, 
growth and differentiation has shown that primary human bone-derived osteoblasts (Doherty et al., 
1994) and a mouse mesenchymal cell line (CRL-12424) attached and spread on the coral (Porites 
lutea) surface displaying a fibroblast-like morphology (Gravel et al., 2006). A similar study using the 
same cell line demonstrated cell proliferation on the surface of two corals (Millepora dichotoma and 
Porites lutea) with temporal expression of alkaline phosphatase and osteocalcin (measures of 
osteogenic differentiation) and evidence of mineralization (Abramovitch-Gottlib et al., 2006). Cui et al 
showed similar results in vitro with adipose-derived stem cells from dogs (Cui et al., 2007). In vivo, an 
early study reported successful healing of cortical and cancellous, non-critical and critical sized bone 
defects in dogs using four different corals; Porites, Goniopora, Favites or Lobophyllia (Guillemin et al., 
1987) and Gao et al reported superior healing of a segmental tibial defect in sheep with coral 
compared to tricalcium phosphate (Ohgushi, 1997). However, these early successes have been 
followed by reports of the inability of coral alone to support effective bone healing (Galea et al., 1998; 
Laza et al., 2007; Mygind et al., 2007).  
 
In common with other synthetic CaP bone substitutes, corals have been shown to have limited 
osteoinductive capacity and it is only with the addition of osteogenic cells onto the coral construct 
that ectopic bone formation is demonstrated (Chen et al., 2007; Ohgushi, 1997; Zhang et al., 2007b). 
Therefore many studies investigating the ability of coral to support bone healing in vivo have included 
the use of osteogenic growth factors or cells to enhance the osteoinductive capability of the construct. 
In a rabbit model of spinal fusion, a Biocoral/collagen scaffold with bovine-derived bone protein 
extract resulted in solid fusions compared to scaffold alone (Mygind et al., 2007): a bone 
morphogenetic protein (BMP) loaded coral scaffold also improved healing in a canine long bone defect 
(Harris and Cooper, 2004) and rabbit calvarial defect (Hou et al., 2007). Cui et al showed that 
enhanced healing occurred at 12 and 24 weeks for a cranial defect in dogs when adipose-derived 
autologous stem cells were added to the coral scaffold (Cui et al., 2007). In the group which received 
coral alone, there was minimal new bone formation and much of the coral had been resorbed by 24 
weeks leaving an empty defect. Similar results were reported by Geiger et al in a rabbit radial defect 
(Geiger et al., 2007) and Louisia et al in a rabbit ulnar defect (Louisia et al., 1999) with coral alone 
showing minimal bone formation but healing enhanced by the addition of autologous bone marrow 
stromal cells. Both studies used Biocoral® which is a commercially available bone substitute material 
from purified coral (Porites sp.) exoskeletons (Table 1).  The coral is chemically treated to remove 
amino acids, artefacts and foreign bodies, but there is no alteration to its chemical or crystalline 
structure (Cirutteau, 1979; White, 1997). Geiger et al (Geiger et al., 2007) and Louisia et al (Louisia et 
al., 1999) both also reported substantial resorption of the coral scaffold after several weeks - a finding 
that is supported by others (Bensaid et al., 2005; Guillemin et al., 1987; Ohgushi, 1997). 
 
Based on these results, Louisia et al suggested that resorption of the coral scaffold could be one of the 
main benefits of its use as a bone tissue construct compared to other, more frequently used ceramics 
such as hydroxyapatite. One of the perceived disadvantages of using CaP ceramics clinically is the 
relatively slow resorption rate. Although some formulations, such as those with a greater proportion 
of  tri-calcium phosphate, have a faster resorption rate, in general CaP resorption is slow and 
hydroxyapatite (the most commonly used synthetic bone graft material) can remain at the 
implantation site for several years (von Doernberg et al., 2006). One of the goals of bone tissue 
engineering research is to produce a scaffold that is removed at the same rate as new bone is laid 
down so that it supports, but does not impede, bone repair. Some synthetic bone substitutes such as 
calcium sulphate (Cook and Cook, 2009) are resorbed too quickly to support bone cell attachment and 
bone growth, so could the calcium carbonate skeleton of coral be the optimum material?  
 
Although these early results of Louisia et al and others showed promise, as with many in vivo studies, 
they lacked meaningful control groups and favoured inclusion of an empty defect group over the more 
useful positive control. This was rectified in the group’s subsequent studies which compared the cell-
seeded coral scaffolds to clinically relevant control groups such as coral mixed with fresh bone 
marrow (Petite et al., 2000) and defects filled with autograft (Viateau et al., 2007). Further study by 
this group, and others, showed that resorption rate of the coral scaffold is very finely balanced. 
Tuominen et al reported that adding BMP to the coral scaffold accelerated the rate of resorption 
(Tuominen et al., 2000). Furthermore, the addition of fresh bone marrow (Petite et al., 2000) or 
vascular endothelial growth factor (VEGF)-producing bone marrow stromal cells (Geiger et al., 2007) 
caused the scaffold to resorb too quickly resulting in bone formation rates lower than those seen with 
cell-seeded constructs. This is in direct contrast to the enhanced bone formation rates found when 
bone marrow or VEGF was added to a CaP scaffold (Clarke, 2007) and suggests that, with further 
development, it may indeed be possible to engineer materials with resorption rates tailored to a 
specific clinical application. Certainly, coral scaffolds seeded with osteogenic cells showed promise in 
these studies and may provide a more appropriate scaffold for cell-based therapies than CaP ceramics.  
When compared with autograft control, cell-seeded coral scaffolds showed similar bone formation 
rates, however, radiographically, complete bridging of the defect was superior in the autograft group 
(Viateau et al., 2007) and this may affect clinical outcomes. Furthermore, Bensaid et al, who also 
investigated the ability of MSC-loaded coral scaffolds to repair large bone defects in sheep, found that 
the coral scaffold resorbed too quickly to support bone formation in most instances, even with the 
cell-loaded constructs (Bensaid et al., 2005). Differences in experimental protocols may account for 
the discrepancy between these and the results of Petite’s group (Louisia et al., 1999; Petite et al., 2000; 
Viateau et al., 2007) as Bensaid et al loaded their scaffold with 640 times more cells and so may have 
provided too much stimulus for resorption similar to that seen with whole bone marrow and growth 
factors.  
 
An alternative to using coral directly as a scaffold to support bone growth was first investigated by 
White and Shors in 1972, when they successfully fabricated replicas of the coral structure from TiO2, 
Al2O3 and HA into bone-like plugs (White et al., 1972). In 1974, Roy and Linnehan took a simpler 
biomimetic approach, employing the direct conversion of coral calcium carbonate skeletons into HA 
(termed coralline HA) (Roy and Linnehan, 1974). The years of scientific research that followed have 
resulted in the development of coral-based commercially available products for bone repair (Table 1). 
These products (Pro-OsteonTM 200R, Pro-OsteonTM 500R) are only partially converted and so have an 
outer HA layer (2-5 m thick) with an inner aragonite core (White and Shors, 1986; White and Shors, 
1989). This may provide a solution to the problem of expeditious resorption of the coral scaffold when 
too much of a stimulus is given: the outer HA layer may slow down the resorption rate, yet the more 
soluble inner core will counter the slow remodeling typical of bone substitutes produced from 
unadulterated HA. One concern with HA coated corals in vivo is that, when the HA coating is breached, 
fast resorption of the core will result in a massive increase in localized extracellular calcium and this, 
as much as the lack of a physical scaffold, may impede bone growth. There is some evidence that, 
although small amounts of calcium will enhance bone cell proliferation and differentiation, too much 
may inhibit both osteoblast (Maeno et al., 2005) and osteoclast (Hall, 1994; Yamada et al., 1997; Zaidi 
et al., 1989) function.  
 
In practice, however, the coralline HA scaffold has shown very little ability to resorb. Bensaid et al 
reported that there was little evidence of resorption of a Pro-Osteon Pro-OsteonTM 200R scaffold in 
a sheep long bone defect even after 16 weeks when the majority of an unconverted coral scaffold had 
been resorbed (Bensaid et al., 2005) and in a clinical trial of Pro-Osteon 500R as an alternative to 
autograft for hind foot arthrodesis in ten patients, the Pro-Osteon was still visible on x-ray more 
than six years after surgery (Coughlin et al., 2006). Furthermore, others have shown that Pro-
Osteon 500R did not support ectopic bone formation even when seeded with osteogenic cells, 
unlike conventional CaP scaffolds (Harris and Cooper, 2004). A review by Shors suggests resorption 
rates for coralline HA in a canine model of 2-5% per year in cancellous sites and 25% per year in 
cortical defects compared to rates of 65% in 2 weeks for the natural coral graft (Shors, 1999). It is 
thought that the inability of coralline HA to be resorbed in vivo is due to the highly crystalline nature 
of the HA coating, which is less soluble (Harris and Cooper, 2004). Therefore, although Pro-Osteon 
can conduct bone formation and has been shown to be an effective bone graft for several applications 
(Coughlin et al., 2006), it should be considered a permanent or slow-resorbing biomaterial and does 
not provide the half-way house of resorption rate between coral and CaP that might have been 
expected.  
 
Current commercially available materials use high pressure-temperature synthesis to achieve the HA 
coating on the coral surface. Several other fabrication techniques, such as replication and microwave 
synthesis, have also been investigated (table 2). Recently, research into the use of corals as bone 
substitutes has focused on the hydrothermal conversion of alternative species such as a coral from the 
Gulf of Mannar, off the coast of India (Sivakumar et al., 1996); modifications to the conversion process 
such as the addition of a second coating step to improve the mechanical properties (Hu et al., 2001); 
or the use of alternative, more sustainable species (Abramovitch-Gottlib et al., 2006).  The slow 
growth rate of corals makes sustainability a major concern for their continued use in bone tissue 
engineering. To meet the market demand, BiometInterpore (manufacturers of Pro-OsteonTM ) 
requires 2-4 tons of coral per year from the Pacific and Indian Oceans (Ritter, 1997).   
 Since 1990, all species of stony coral have been listed under the Convention on International Trade in 
Endangered Species (CITES) treaty Appendix II (vulnerable to exploitation but not yet at risk of 
extinction) (Harriott, 2003). Compared to the damage inflicted on coral reefs by environmental 
stresses such as pollution and storm damage and by intensive fishing methods such as dynamite 
fishing, commercial coral harvesting probably has a relatively low impact. However, extensive farming 
of accessible reefs may lead to localized habitat destruction and overfishing of one or two target 
species may mean the reef overall is maintained but individual species are lost (Harriott, 2003).  
 
Options for farming corals include strict management and control over the reef such as occurs in 
Australia, on the Great Barrier Reef in particular, or culturing corals in aquaria – one of the benefits 
cited by Abramovitch-Gottlib et al for using the hydrocoral Millepora dichotoma in their recent studies 
(Abramovitch-Gottlib et al., 2006) For some of the branching corals, small pieces can be harvested 
grown in aquaria to commercially suited sizes and sold, by which time stocks in the wild have also 
replenished. In general, there is a location- and species-specific answer to the question of whether 
coral can be harvested sustainably (Harriott, 2003). Some algal species also have a calcareous 
skeleton and with a growth rate of 2.6cm/year, compared to an average of 1cm/year for coral species 
(Harriott, 2003), they may provide a more sustainable alternative for bone tissue engineering (Felicio-
Fernandes and Laranjeira, 2000).  
 
Algae 
There are three types of algae – red, brown and green, but it is species of red algae (phylum 
Rhodophyta), specifically a group of coralline algae, that have been used in bone tissue engineering. 
Coralline algae deposit calcium carbonate, in the form of calcite, in their cell wall and, in warm marine 
environments, have been shown to participate in reef building (Castro and Huber, 2008).  
 
Unlike the corals, coralline algae have not been used in the native form as a scaffold or bone substitute 
but have instead been converted to calcium phosphate using similar hydrothermal conversion 
methods as those used to synthesise Pro-Osteon. This was first described using Corallina officinalis 
by Roy and Linnehan in 1974 (Roy and Linnehan, 1974) and later developed by Kasperk et al in the 
late 1980’s (Kasperk et al., 1988). This latter research group has published an extensive body of work 
in the intervening decades. Despite the fact that the pores of this algae, although interconnected, are 
approximately 5-10 m (figure 1) (Schopper et al., 2005; Walsh et al., 2008) and therefore considered 
suboptimal for tissue and vascular ingrowth (Felicio-Fernandes and Laranjeira, 2000), the coralline 
HA scaffold has been shown to support the attachment, proliferation and differentiation of both 
primary human bone-derived cells (Turhani et al., 2005a; Turhani et al., 2005c) and mesenchymal 
cambial-layer precursor cells (Turhani et al., 2005b). Furthermore, a commercially available CaP 
product derived from C. officinalis, AlgiPore (also marketed as C GRAFT, Algisorb and AlgOss) has a 
relatively long history of clinical use in maxilla sinus grafting: in 2005, Ewers reported the long term 
follow-up (up to 13 years) of over 200 sinus grafts with a 95.6% survival rate (Ewers, 2005).  
 
As the algal-derived HA is produced by similar methods to coral-derived HA, there are similar 
concerns about the resorptive capacity of this graft. Ewers reported that there was only a 14% volume 
loss of the material after six months in his clinical study of AlgiPore and some graft material was still 
visible even after six years (Ewers, 2005). In an attempt to increase the resorption rate, biphasic CaP 
materials were produced from the algal template, with various ratios of HA to  tricalcium phosphate 
(TCP) (Spassova et al., 2007). In a cortico-cancellous defect model in sheep, biphasic materials with 
HA:TCP ratios of 50:50 and 30:70 did show a statistically significant decrease in residual graft volume 
and an increase in bone volume after 6 months compared to 100% HA but there was no further 
reduction in the material volume of any of the materials at 12 months and considerable amounts of 
even the 30:70 graft remained (Schopper et al., 2005).  
 
Another strategy for counteracting the lack of resorption of the coralline HA grafts may be to use 
alternative production techniques. In 2008, Walsh et al described production of an HA bone graft from 
C. officinalis using low temperature hydrothermal synthesis that resulted in semi-amorphous HA 
rather than the highly crystalline material produced by previous methods (Walsh et al., 2008). In 
theory, this material should be more resorbable in vivo but we must await further publications 
confirming both this and biocompatibility of the graft.  
 
Cuttlefish 
Although there are tens of thousands of marine unicellular and multicellular organisms that produce 
some form of mineral, species from only four further invertebrate phyla have been investigated for 
bone tissue engineering, namely Mollusca, Arthropoda, Echinodermata and Porifera (Table 3).  Of 
these, cuttlefish (Phylum Mollusca, Class Cephalopoda) have been the most extensively studied. Four 
groups have described the conversion of a single species of cuttlefish, Sepia officinalis, from the 
natural aragonite calcium carbonate mineral to carbonated HA (Ivankovic et al., 2009; Kasioptas et al., 
2010; Lee et al., 2007; Rocha et al., 2005b). The resulting structure (figure 1) has a high percentage 
porosity (80%-94%) and with pore sizes in the range of 200-600 m (Kim et al., 2008) may provide a 
more optimized scaffold for bone tissue ingrowth and revascularization than either coral or coralline 
algae.  
 
To date, however, this remains untested as the current in vitro and in vivo testing published is of a 
very limited nature (Rocha et al., 2006; Rocha et al., 2005a) or has only been presented in short paper 
form (Kim et al., 2008). In vitro studies were short-term (up to 72 hours) and were concerned with 
initial biocompatibility of the material and therefore tested proliferation and alkaline phosphatase 
expression of primary osteoblasts in the presence of, and not directly attached to, powdered converted 
cuttlefish bone (Rocha et al., 2005a) or whole constructs (Rocha et al., 2006). No cytotoxic results 
were reported. In vivo, no inflammatory response to converted cuttlefish (Sepia esculenta) implanted 
in a rabbit femoral condylar defect was reported but no quantification of healing or bone formation 
was performed (Kim et al., 2008). One study has suggested that cuttlefish "bone" can directly support 
bone formation, without requiring hydrothermal conversion to HA, and may be suitable as a potential 
xenograft for bone healing as Sepia officinalis was tested in a bone defect model against currently 
available synthetic graft and xenograft materials (Okumus and Yildirim, 2005). Again, this requires 
further investigation and there are some concerns about the mechanical strength of the raw material 
as it is malleable and easily shaped, but in general this represents a potential new direction for bone 
tissue engineering. Carbonated HA is closer to the chemistry of natural human bone than 
stoichiometrically pure HA (Bigi et al., 1997)and has been shown experimentally to have enhanced 
biocompatibility (Ellies et al., 1988; Landi et al., 2003). The methods described to convert cuttlefish 
aragonite seemed to result in substitution of carbonate ions in a similar location within the HA 
structure to bone (Ivankovic et al., 2009; Kasioptas et al., 2010) and with cuttlefish in relative 
abundance in tropical and temperate seas (Okumus and Yildirim, 2005), sustainability may not be a 
concern making this resource of significant interest. 
 
Arthropoda and Echinodermata 
Ion substitution of HA has been a strategy employed extensively to improve the biological 
performance of calcium phosphate and two groups of the phylum Echinodermata, sea stars (class 
Asteroidea) and sea urchins (class Echinoidea), have ossicles and spines made of Mg-rich calcite. 
Ossicles from the seastar, Pisaster giganteus, have been shown to support human bone-derived 
osteoblast and human bone marrow stromal cell attachment directly to the porous structure (Martina 
et al., 2005) whereas spines from two species of sea urchins, Heterocentrotus trigonarius and 
Heterocentrotus mammillatus, were converted to CaP before use (Vecchio et al., 2007b) The biogenic 
Mg-rich calcite spines resulted in Mg-substituted tricalcium phosphate (TCP) rather than HA when 
converted. The structure had pores in the range of 20-50 m with trabecular struts of 100 m and 
showed no inflammatory reaction and bony apposition when implanted in a rat femoral defect model 
(Vecchio et al., 2007b). These are very early results but using an ion-rich biogenic source of calcite or 
aragonite as a starting material may provide scaffolds with optimal biocompatibility using simple 
processing methodology, avoiding the need for complex reactions to obtain ion-substitution, such as 
those employed by Kannan et al to obtain fluorine ion substitution during conversion of cuttlefish 
bones (Kannan et al., 2007).  However, most sea urchin spines are too small to be of practical use and 
with only two species currently identified as having spines large enough to provide useful scaffolds, 
sustainability must be a concern.  
 
Conversely, seashells and the exoskeletons of many arthropods such as crab and lobster are large 
enough to provide structures for any application. In a study examining the conversion of Giant clam 
(Tridacna gigas) and conch (Strombus gigas) shells, Vecchio et al showed that even when partially 
converted to HA (i.e. the structure has an outer HA shell and inner CaCO3 core) the mechanical 
strengths were similar to that of human bone perhaps allowing this particular material to be used for 
load bearing applications (Vecchio et al., 2007a). A further advantage of this biogenic source is that 
the large pieces can be machined into any shape. The authors give screws as an example and potential 
application, however, the material is non-porous and even though initial in vivo studies demonstrated 
bone apposition in a rat femoral defect model, with no evidence of material resorption at 6 wks, long 
term removal of the material may be a problem.  
 
Crustacean exoskeletons may provide a solution to this. Studies of lobster (Homarus americanus) 
(Raabe et al., 2005) and the sheep crab (Loxorhynchus grandis) (Chen et al., 2008b) showed that their 
mineralized chitin exoskeletons have excellent material properties, high degrees of strength due to 
the ‘twisted plywood’ structure and, in the case of the lobster, a porous honeycomb structure at the 
micron level. Use of these exoskeletons as graft materials has not been investigated, however, as 
CaCO3 has been shown to support bone growth in some of the studies outline previously, and chitin 
has been extensively studied as part of composite materials for biomedical devices (Khoushab and 
Yamabhai), there is no reason to suppose that crustacean exoskeletons will not support bone 
formation. Even if, however, they are not directly suitable as xenografts, studying their complex 
architecture and morphology may provide inspiration for synthetic nanocomposite material design 
(Chen et al., 2008a; Giraud-Guille et al., 2004).  
 
Porifera 
The final group of marine invertebrates investigated for the ability to support bone formation is the 
sponges (Porifera). Some sponges have a CaCO3 skeleton but the majority has a protein skeleton made 
from spongin with or without additional support from siliceous spicules (Castro and Huber, 2008). 
Spongin is comparable to vertebrate collagen and as such has been extracted for use as a functional 
additive to composite biomaterials. In one study, sponge (Chondrosia reniformis)- derived collagen 
was used in conjunction with silica templating to produce hydrogels which supported attachment and 
growth of an osteoblast-like cell line (Heinemann et al., 2007). Sponges themselves have also been 
examined as suitable scaffolds for bone tissue engineering. In two separate studies, six different 
“unidentified” sponges were found to support human BMSC (Green et al., 2003) and mouse calvarial-
derived primary osteoblasts (Zheng et al., 2007) attachment and differentiation demonstrated by 
alkaline phosphatase expression or activity. Green et al subsequently identified their sponge as 
Spongia officinalis, a Mediterranean bath sponge, and showed that it also supported ectopic bone 
formation when implanted in a subcutaneous pouch athymic mouse model (Green, 2008).  
 
More recently, three sponges from the genus Spongia (S. officinalis, S. zimocca, and S. agaricina) were 
used as precursors, or templates, to produce porous HA scaffolds by a replication technique 
(Cunningham et al., 2010). Of the three sponges examined, Spongia agaricina produced the most 
promising replicated scaffold for bone tissue engineering as it had approximately 60% porosity with 
pore sizes in the range of 100-500 m and 99.9% interconnectivity (figure 1). Therefore sponges 
could prove to be useful on a number of fronts, either as a source of collagen for hydrogel production 
or as an additive to synthetic CaP or polymer scaffolds, as templates for producing biomimetic ceramic 
scaffolds or directly as osteoconductive grafts. There is one serious drawback to the continued use of 
sponges as biomaterials, however, and that is one of sustainability. Sponges have been used for 
centuries for numerous applications, most notably in the cosmetics industry. Those species that 
produce bioactive compounds are also increasingly being sought for use in biomedical fields. Demand 
now far outweighs supply of some species, particularly Mediterranean bath sponges, and has resulted 
in their inclusion on endangered and protected species lists (Baldacconi et al., 2010; Corriero et al., 
2004). Currently, methods of farming these sponges (Corriero et al., 2004; Muller et al., 1999), or of 
transplanting them back into protected areas from which they have become extinct (Baldacconi et al., 
2010) are being investigated. Unless these studies prove successful or alternative species of sponge 
which are not endangered are found, these animals may not prove to be suitable for orthopaedic 
applications in the long term.  
 
Future Directions 
The philosophy of biomimetics has provided a new direction for biomaterial design. Early forays in 
this area began with researchers trying to recreate the natural structure of bone on a microscale by 
mimicking the trabecular porous structure and collagen fibre/mineral composite chemistry and has 
now progressed to mimicking cortical bone on a macroscale, producing materials with a dense outer 
layer and inner cavity (Zhang et al., 2007a). Reproducing the porosity of human bone has provided 
some degree of success but may be limited by production methods, for example the use of synthetic 
performs, which often result in partially closed porous structures with limited connectivity or low 
tortuosity (the ease of a path through the porous structure). This has driven a search for naturally 
occurring porous structures which can either be used directly as scaffolds or to provide templates for 
producing novel biomaterials.  
 
We have seen above that the seas and oceans are a rich source of mineralized organisms that may be 
of benefit for this purpose. Research into these sources is in its relative infancy and there remains 
much work to be done with those already identified and many hundreds more that are yet untapped. 
As we progress towards ‘smart’ biomaterials that are application specific and have tailored resorption 
and osteoconductive profiles, it may be that we can utilize many of these resources – using the more 
resorbable CaCO3 structures directly for short term support, using sources rich in Mg, Si or other ions 
to produce ion-substituted CaP with intermediate resorption profiles, or converting porous CaCO3 
skeletons with optimal pore size and connectivity to provide long term scaffolds for ex vivo bone 
tissue engineering. The opportunities in the marine environment are almost limitless – in fact, as long 
as we ensure from the beginning that the resources we use are truly sustainable, the seabed is the 
limit.  
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Figure Legends 
 
Figure 1. Scanning electron micrographs of (a) cuttlefish (Sepia officinalis), (b) sponge (Spongia 
agaricina), (c) red algae (Corallina officinalis) and (d) coccolithophores (Emiliania 
huxleyi)demonstrating a range of macro and microporous structures. E.huxleyi micrograph courtesy of 
Katherine Fee. 
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 Table 1. Commercially available bone graft products from marine sources. 
 
 
Product Manufacturer 
Country of 
Origin  
Genera Chemistry 
Biocoral Inoteb France 
Porites, 
Acropora, 
Lobophyllia,  
Montastrea, 
Dichocoenia 
CaCO3 
ProOsteon 
200R 
Biomet 
US 
Porites HA/CaCO3 
ProOsteon 
500R 
Biomet 
US 
Goniopora HA/CaCO3 
Algipore DENTSPLY 
Friadent 
Germany  
Corallina 
officinalis 
HA 
 
Table 2. Examples of manufacture processes used to fabricate marine-derived/inspired bone grafts. Key: CS 
= Closed System, autoclave  OP = Open System, reaction vessel  HPT – High Pressure-TemperatureHT – High Temperature TCP = 
Tri-calcium phosphate TCMP = Mg-substituted tri-calcium phosphate  
 
Common 
Name 
Genera/Species  Source  Fabrication Technique  Chemistry Yr Ref 
Clams Tridacna gigas Unspecified 
HT Synthesis with superheated 
steam (CS)  - 180C (20 days)  
Complete transformation 
to HA 
2007 
(Vecc
hio et 
al., 
2007
a) 
Corals 
Goniopora  
Gulf of 
Mannar, 
India 
Microwave irradiation - 800 W 
for 40 mins at 2.45 GHz 
Complete transformation 
to biphasic CaP with HA: 
TCP Phases 
2003 
(Mur
ugan 
and 
Rama
krish
na, 
2004) 
Porites Unspecified 
HT Synthesis with vapour 
pressure (CS)  - 160 - 200C at 1-
2 MPa (8-14hrs)  
Complete transformation 
to HA 
2002 
(Jina
wath 
et al., 
2002) 
Goniopora 
Great 
barrier 
Reef, 
Australian 
(1) Acid digest (5%NaClO); (2) 
HPT Synthesis (CS) - 250C at 
2.8MPa 
Complete transformation 
to a monophasic HA 
2001 
(Hu 
et al., 
2001) 
Goniopora  
Gulf of 
Mannar, 
India 
(1) Pyrolysis 900C (12hrs) 
(2) HPT Synthesis 
HA – Process destroyed 
structure 
1996 
(Sivak
umar 
et al., 
1996) 
Goniopora; Porites 
 
Unspecified 
HPT Synthesis (CS) - 270C at 
103MPa 
Complete transformation 
of coral to a monophasic 
CaP 
1974 
(Roy 
and 
Linne
han, 
1974) 
Goniopora; Porites Unspecified Replication using wax casting 
TiO2, Al2O3 and HA 
synthetic replicas of coral 
structures 
1972 
(Whit
e et 
al., 
1972) 
Cuttlefish 
Sepia officinalis 
New South 
Wales, 
Australia 
Hydrothermal Synthesis with 
superheated steam (CS)  - 80C 
(32hrs) – 190C (1.5hrs) 
Complete transformation 
to a monophasic HA 
2010 
(Kasio
ptas 
et al., 
2010) 
Sepia officinalis  Adriatic Sea 
(1) Pyrolysis 350C (3hrs) 
(2) HT Synthesis, superheated 
steam (CS) - 200C (48 hrs)  
Complete transformation 
to monophasic HA 
2009 
(Ivan
kovic 
et al., 
2009) 
Sepia esculenta Unspecified 
(1) Acid digest (4%NaClO);  
(2) Pyrolysis 180C (16hrs) 
Predominantly HA 2008 
(Kim 
et al., 
HT Synthesis superheated steam 
(CS) - 200C (24 hrs)  
2008) 
Red algae 
Corallina officinalis 
Donegal, 
Ireland 
(1) Pyrolysis 650C (12hrs) 
(2) LP Hydrothermal Synthesis - 
(OS)  - 100C (24hrs) 
Complete transformation 
to a biphasic CaP with  
95 % HA: TCP Phases 
2008 
(Wals
h et 
al., 
2008) 
Rhodophyta 
(species 
unspecified) 
Santa 
Catarina 
Island  
(1) Acid digest (10%NaClO); (2) 
HT Hydrothermal Synthesis  (CS) 
superheated steam - 200C 
(48hrs) 
Complete transformation 
to a monophasic HA with 
trace Mg 
2+ 
Na
+
 ions 
2000 
(Felici
o-
Ferna
ndes 
and 
Laran
jeira, 
2000) 
Sea urchins 
Paracentrotus 
lividus;                
Heterocentrotus 
mammillatus 
Unspecified Precipitation- 20C (2 Mths) HA 2009 
(Marc
hegia
ni et 
al., 
2009) 
Heterocentrotus 
mammillatus 
Heterocentrotus 
trigonarius 
Unspecified 
HT Hydrothermal Synthesis with 
superheated steam (CS)  - 180C 
Complete transformation 
of spines to TCMP 
2007 
(Vecc
hio et 
al., 
2007
b) 
Unspecified Unspecified 
Replication using polymer 
casting 
CaCO3 2006 
(Guill
emin 
et al., 
1987) 
Snails Pomacea lineata Unspecified 
Precipitation- Room 
Temperature – 7, 14, 30 days 
Aragonite with HA coating  2010 
(dePa
ula et 
al., 
2010) 
Sponges Spongia agaricina Caribbean 
Replication using HA slurry and 
sintering at 1300
o
C (5hrs) 
HA 2010 
(Cunn
ingha
m et 
al., 
2010) 
 Table 3. Examples of mineralizing marine organisms. Those that have already been investigated 
for bone tissue engineering are highlighted in bold. 
 
Phylum Class Common Name Skeletal Mineral 
    
Heterokontophyta Bacillariophyta Diatoms Silica 
Haptophyta Prymnesiophyceae Coccolithophorids CaCO3 
Radiolaria Polycystina Radiolarians silica 
Foraminifera Granuloreticulosa Foraminiferans CaCO3 
Rhodophyta Florideophyceae Red algae CaCO3/calcite 
Ectoprocta Stenolaemata Bryozoans CaCO3 
Porifera Demospongia Sponges CaCO3 and/or silica 
Cnidarians Anthozoa Corals CaCO3/aragonite 
Mollusca Gastropoda Snails, limpets CaCO3/aragonite 
 Bivalvia Clams, mussels CaCO3/aragonite 
 Cephalopods Squid, cuttlefish CaCO3/aragonite 
Arthropoda Crustacea Lobster, crab, shrimp CaCO3/aragonite 
Brachiopoda e.g. Lingulata Lampshells CaCO3 or CaPO4 
Echinodermata Asteroidea Starfish CaCO3/calcite 
 Echinoidea Sea urchins CaCO3/calcite 
 Ophiuroidea Brittle stars CaCO3/calcite 
 Holothuroidea Sea Cucumbers CaCO3/calcite 
 
 
 
